Dmitriy Kogan, Kelly Newton, Eldrige Pineda, Ameldia Evans, Huimin Guo, Norio Azumi, Philip Cohen, Cristina Reichner, Eric Anderson
SESSION TYPE: Miscellaneous Cases IIIPRESENTED ON: Wednesday, October 24, 2012 at 11:15 AM - 12:30 PMINTRODUCTION: Trastuzumab is an IgG1 humanized monoclonal antibody which targets Human Epidermal Growth Factor Receptor 2 (HER2). Since its development in 1998, Trastuzumab has been used for treatment of HER2 positive breast cancer. Pulmonary complications associated with Trastuzumab include acute lung injury, acute pneumonitis, organizing pneumonia, infusion-related reaction, and bronchospasm. We report a case of pulmonary sarcoidosis that developed after Trastuzumab therapy...
October 1, 2012: Chest